Combination strategies with checkpoint immunotherapy and inducers of immunogenic cell death (ICD) in immune competent syngeneic models

被引：0
|
作者：
McKenzie, A. [1 ]
Papadopoulou, N. [1 ]
Yin, Y. [1 ]
Jiang, S. [1 ]
Wrigley, J. [2 ]
King, J. [3 ]
Garland, R. [4 ]
Williams, N. [5 ]
Kumari, R. [6 ]
机构：
[1] Crown Biosci UK Ltd, Sci Operat, Loughborough, Leics, England
[2] Crown Biosci UK Ltd, Vitro Operat, Loughborough, Leics, England
[3] Crown Biosci UK Ltd, Vivo Operat, Loughborough, Leics, England
[4] KWS Biotest, Analyt Serv, Bristol, Avon, England
[5] KWS Biotest, Bristol, Avon, England
[6] Crown Biosci UK Ltd, CBUK, Loughborough, Leics, England
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32931-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
338
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 50 条
  • [41] Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy
    Zhou, Lei
    Zhang, Pengcheng
    Wang, Hao
    Wang, Dangge
    Li, Yaping
    ACCOUNTS OF CHEMICAL RESEARCH, 2020, 53 (09) : 1761 - 1772
  • [42] Development of immune-competent mouse models of ovarian cancer for targeted radiation therapy in combination with immunotherapy
    Xu, Lu
    Metebi, Abdullah
    Singh, Satyendra
    Erder, Ece
    Kauffman, Nathan
    Nayback, Chelsea
    Schnitzer, Jan
    Zinn, Kurt
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [43] Quantitative cell-based bioassays to advance individual or combination immune checkpoint immunotherapy
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie Jey
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Quantitative cell-based bioassays to advance individual or combination immune checkpoint immunotherapy
    Grailer, Jamison
    Stecha, Pete
    Garvin, Denise
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie Jey
    CANCER RESEARCH, 2017, 77
  • [45] Armed Myxoma virus demonstrates efficacy in syngeneic tumor models alone and in combination with immune checkpoint inhibitors.
    Franco, Lina S.
    Torres-Dominguez, Lino E.
    Mamola, Joseph
    de Matos, Ana L.
    Abrantes, Mario
    Walker, Benjamin S.
    Tacner, Zachary
    Kien, Cassandra
    Elliott, Natalie M.
    McFadden, Grant
    Sharp, Leslie L.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
  • [46] Combination Immunotherapy with Oncolytic Virus Induces Immunogenic Cell Death and T-cell Proliferation in Colon Cancer
    Wong, Paul
    Qiao, Guilin
    Seth, Prem
    Prabhakar, Bellur
    Maker, Ajay V.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S30 - S30
  • [47] Combination of the angiogenesis inhibitor lucitanib with immune checkpoint blockade augments anti-tumor activity in syngeneic models
    Dusek, Rachel
    Robillard, Liliane
    Harding, Thomas
    Simmons, Andrew
    Minh Nguyen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [48] Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
    Du, Fei
    Wang, Guojun
    Dai, Qian
    Huang, Jiang
    Li, Junxin
    Liu, Congxing
    Du, Ke
    Tian, Hua
    Deng, Qiwei
    Xie, Longxiang
    Zhao, Xin
    Zhang, Qimin
    Yang, Lan
    Li, Yaling
    Wu, Zhigui
    Zhang, Zhuo
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [49] Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
    Zhou, Zhaokai
    Mai, Yumiao
    Zhang, Ge
    Wang, Yingjie
    Sun, Pan
    Jing, Zhaohe
    Li, Zhengrui
    Xu, Yudi
    Han, Bo
    Liu, Jian
    CANCER LETTERS, 2024, 598
  • [50] Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy
    Zhu, Hanzhang
    Shan, Yuqiang
    Ge, Ke
    Lu, Jun
    Kong, Wencheng
    Jia, Changku
    CELLULAR ONCOLOGY, 2020, 43 (06) : 1203 - 1214
12345